Logo image of AMTD

AMTD IDEA GROUP (AMTD) Stock Fundamental Analysis

NYSE:AMTD - New York Stock Exchange, Inc. - US00180G3048 - ADR - Currency: USD

1.01  -0.05 (-4.86%)

After market: 1.0299 +0.02 (+1.97%)

Fundamental Rating

3

AMTD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 231 industry peers in the Capital Markets industry. Both the profitability and the financial health of AMTD get a neutral evaluation. Nothing too spectacular is happening here. AMTD has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AMTD had positive earnings in the past year.
AMTD had a positive operating cash flow in the past year.
In the past 5 years AMTD has always been profitable.
Each year in the past 5 years AMTD had a positive operating cash flow.
AMTD Yearly Net Income VS EBIT VS OCF VS FCFAMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

The Return On Assets of AMTD (2.28%) is comparable to the rest of the industry.
AMTD's Return On Equity of 2.96% is on the low side compared to the rest of the industry. AMTD is outperformed by 67.53% of its industry peers.
Industry RankSector Rank
ROA 2.28%
ROE 2.96%
ROIC N/A
ROA(3y)8.23%
ROA(5y)10.23%
ROE(3y)9.35%
ROE(5y)11.59%
ROIC(3y)N/A
ROIC(5y)N/A
AMTD Yearly ROA, ROE, ROICAMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 87.41%, AMTD belongs to the best of the industry, outperforming 97.40% of the companies in the same industry.
In the last couple of years the Profit Margin of AMTD has declined.
With a decent Gross Margin value of 70.37%, AMTD is doing good in the industry, outperforming 73.59% of the companies in the same industry.
In the last couple of years the Gross Margin of AMTD has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 87.41%
GM 70.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.14%
PM growth 5Y-8.79%
GM growth 3Y-11.01%
GM growth 5Y-6.72%
AMTD Yearly Profit, Operating, Gross MarginsAMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

5

2. Health

2.1 Basic Checks

The number of shares outstanding for AMTD has been increased compared to 1 year ago.
The number of shares outstanding for AMTD has been increased compared to 5 years ago.
AMTD has a worse debt/assets ratio than last year.
AMTD Yearly Shares OutstandingAMTD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
AMTD Yearly Total Debt VS Total AssetsAMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

AMTD has an Altman-Z score of 2.34. This is not the best score and indicates that AMTD is in the grey zone with still only limited risk for bankruptcy at the moment.
AMTD has a Altman-Z score of 2.34. This is in the better half of the industry: AMTD outperforms 73.59% of its industry peers.
The Debt to FCF ratio of AMTD is 54.95, which is on the high side as it means it would take AMTD, 54.95 years of fcf income to pay off all of its debts.
AMTD has a Debt to FCF ratio (54.95) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.14 indicates that AMTD is not too dependend on debt financing.
AMTD has a Debt to Equity ratio of 0.14. This is in the better half of the industry: AMTD outperforms 78.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 54.95
Altman-Z 2.34
ROIC/WACCN/A
WACCN/A
AMTD Yearly LT Debt VS Equity VS FCFAMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

AMTD has a Current Ratio of 10.62. This indicates that AMTD is financially healthy and has no problem in meeting its short term obligations.
AMTD has a Current ratio of 10.62. This is amongst the best in the industry. AMTD outperforms 92.64% of its industry peers.
AMTD has a Quick Ratio of 10.62. This indicates that AMTD is financially healthy and has no problem in meeting its short term obligations.
AMTD has a better Quick ratio (10.62) than 92.64% of its industry peers.
Industry RankSector Rank
Current Ratio 10.62
Quick Ratio 10.62
AMTD Yearly Current Assets VS Current LiabilitesAMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

0

3. Growth

3.1 Past

AMTD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.23%.
Measured over the past years, AMTD shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -65.03% on average per year.
The Revenue for AMTD has decreased by -71.05% in the past year. This is quite bad
The Revenue for AMTD have been decreasing by -39.76% on average. This is quite bad
EPS 1Y (TTM)-69.23%
EPS 3Y-83.92%
EPS 5Y-65.03%
EPS Q2Q%-80%
Revenue 1Y (TTM)-71.05%
Revenue growth 3Y-60.17%
Revenue growth 5Y-39.76%
Sales Q2Q%-50.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMTD Yearly Revenue VS EstimatesAMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
AMTD Yearly EPS VS EstimatesAMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 1.66, which indicates a rather cheap valuation of AMTD.
Based on the Price/Earnings ratio, AMTD is valued cheaply inside the industry as 97.84% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.25. AMTD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1.66
Fwd PE N/A
AMTD Price Earnings VS Forward Price EarningsAMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

AMTD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMTD is cheaper than 61.90% of the companies in the same industry.
63.20% of the companies in the same industry are more expensive than AMTD, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.73
EV/EBITDA 70.8
AMTD Per share dataAMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMTD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMTD IDEA GROUP

NYSE:AMTD (5/30/2025, 8:04:00 PM)

After market: 1.0299 +0.02 (+1.97%)

1.01

-0.05 (-4.86%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-24 2025-03-24
Earnings (Next)N/A N/A
Inst Owners1.88%
Inst Owner Change30.58%
Ins OwnersN/A
Ins Owner Change0%
Market Cap81.03M
Analysts82.86
Price TargetN/A
Short Float %0.17%
Short Ratio1.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.66
Fwd PE N/A
P/S 1.5
P/FCF 15.73
P/OCF 15.7
P/B 0.05
P/tB 0.06
EV/EBITDA 70.8
EPS(TTM)0.61
EY60.4%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY6.36%
OCF(TTM)0.06
OCFY6.37%
SpS0.67
BVpS19.84
TBVpS18.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.28%
ROE 2.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 87.41%
GM 70.37%
FCFM 9.54%
ROA(3y)8.23%
ROA(5y)10.23%
ROE(3y)9.35%
ROE(5y)11.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.14%
PM growth 5Y-8.79%
GM growth 3Y-11.01%
GM growth 5Y-6.72%
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 54.95
Debt/EBITDA 42.12
Cap/Depr 0.15%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion 99.23%
Profit Quality 10.91%
Current Ratio 10.62
Quick Ratio 10.62
Altman-Z 2.34
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.02%
Cap/Sales(5y)0.01%
Profit Quality(3y)19.87%
Profit Quality(5y)57.47%
High Growth Momentum
Growth
EPS 1Y (TTM)-69.23%
EPS 3Y-83.92%
EPS 5Y-65.03%
EPS Q2Q%-80%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-71.05%
Revenue growth 3Y-60.17%
Revenue growth 5Y-39.76%
Sales Q2Q%-50.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-100.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-87.1%
FCF growth 3Y-77.2%
FCF growth 5Y-62.66%
OCF growth 1Y-87.1%
OCF growth 3Y-77.19%
OCF growth 5Y-62.65%